The mucopolysaccharidoses comprise a heterogeneous group of inborn errors of metabolism. Usually these disorders culminate in severe disability over many years, and only seldom result in death in infancy. The prospect of gaining a certain amount of control over the incidence and progression of these rare but costly diseases amply justifies the large amount of effort and expense devoted to research into their causation.